# Agentic AI & RAAG-Based Decision Support Layer

## Motivation
While the preceding hypotheses focus on predictive performance, failure modes, and uncertainty, real-world clinical deployment requires an additional system-level layer that determines **how predictions should be used safely**.

In high-stakes medical settings, the key challenge is not only predicting malignancy, but deciding **when a prediction is reliable enough to act upon**. To address this, we introduce an **Agentic AI decision-support layer** built using **Retrieval-Augmented and Action-Guided (RAAG)** principles.

---

## Role of the Agentic Layer
The Agentic AI layer does **not** perform diagnosis and does **not** replace clinicians. Instead, it operates on top of the trained machine learning model to **orchestrate downstream clinical actions** based on risk and reliability signals.

The agent transforms model outputs into **decision guidance**, ensuring safety, interpretability, and clinical alignment.

---

## Inputs to the Agent
The agent retrieves structured signals produced by the predictive pipeline:

- Predicted malignancy probability
- Predictive entropy (uncertainty)
- Confidence margin (distance from decision threshold)
- Tumor size category (Small / Medium / Large)
- Known failure patterns identified in prior analyses (H3, H4, H5)

These inputs are **retrieved and contextualized** before any action is recommended.

---

## RAAG Decision Framework
The agent follows a **Retrieval-Augmented and Action-Guided (RAAG)** paradigm:

1. **Retrieval**
   - Extract uncertainty metrics and cohort-specific risk indicators
   - Identify whether the sample belongs to known failure-prone regimes

2. **Reasoning**
   - Assess prediction reliability using uncertainty and failure context
   - Weigh model confidence against known limitations

3. **Action Guidance**
   - Recommend appropriate clinical pathways:
     - Accept prediction
     - Escalate for radiologist review
     - Request follow-up imaging
     - Flag for audit or monitoring

---

## Illustrative Decision Policy (Conceptual)
The following illustrates the agent’s decision logic at a conceptual level:

- High uncertainty → escalate for expert review  
- Small tumor + low confidence margin → recommend secondary evaluation  
- High-confidence malignant prediction → prioritize diagnostic follow-up  
- Standard-risk cases → proceed with routine workflow  

This logic is intentionally transparent, auditable, and clinically interpretable.

---

## Relationship to Experimental Findings
The Agentic AI layer integrates insights from all hypotheses:

- **H2:** Adjusts sensitivity based on class imbalance risks  
- **H3:** Prevents repeated failures in known error clusters  
- **H4:** Compensates for feature collapse in small tumors  
- **H5:** Converts predictive uncertainty into safety actions  

Thus, the agent serves as a **cross-hypothesis integration mechanism**.

---

## Clinical Safety and Ethics
The agent is explicitly designed to:
- Support clinician decision-making
- Prevent blind automation
- Preserve human-in-the-loop oversight
- Enable auditability and governance

This design aligns with best practices for responsible clinical AI deployment.

---

## Significance
By incorporating an Agentic AI layer, this project moves beyond predictive modeling toward **deployable, safety-aware clinical AI system design**. The RAAG-based approach demonstrates how uncertainty-aware machine learning outputs can be translated into reliable and ethical decision-support workflows.
